T1	Concept 16 25	mutations
T2	Concept 5 15	pathogenic
R1	has-property Arg1:T1 Arg2:T2	
T3	Concept 33 53	human telomerase RNA
R2	in-context Arg1:T1 Arg2:T3	
T6	Concept 71 84	wellconserved
T4	Concept 85 87	PK
R4	has-property Arg1:T4 Arg2:T6	
R5	in-place Arg1:T1 Arg2:T4	
R6	has-part Arg1:T3 Arg2:T4	
T5	Concept 197 207	SARS-CoV-2
T7	Action 208 217	infection
T8	Action 181 193	confirmation
T9	Concept 308 314	RT-PCR
T10	Concept 249 306	real-time reverse transcription polymerase chain reaction
*	same-as T10 T9
R3	target Arg1:T8 Arg2:T7	
R7	subject Arg1:T7 Arg2:T5	
T11	Concept 243 248	viral
R8	in-context Arg1:T10 Arg2:T11	
R9	causes Arg1:T10 Arg2:T8	
T12	Concept 351 355	PEDV
T13	Action 356 365	infection
R10	subject Arg1:T13 Arg2:T12	
T14	Concept 430 448	growth performance
T15	Concept 420 429	decreased
R11	has-property Arg1:T14 Arg2:T15	
R12	causes Arg1:T13 Arg2:T14	
T16	Concept 384 388	pigs
R13	in-context Arg1:T14 Arg2:T16	
T17	Concept 334 343	mortality
T18	Concept 369 374	lower
T19	Concept 378 383	older
T20	Concept 384 388	pigs
R14	has-property Arg1:T17 Arg2:T18	
R15	has-property Arg1:T20 Arg2:T19	
R16	target Arg1:T13 Arg2:T20	
R17	in-context Arg1:T17 Arg2:T13	
T21	Concept 449 453	ACE2
T22	Concept 477 486	AT2 cells
T23	Concept 508 517	AT1 cells
T24	Concept 519 542	airway epithelial cells
T25	Concept 544 555	fibroblasts
T26	Concept 557 574	endothelial cells
T27	Concept 580 591	macrophages
T28	Action 496 504	detected
R18	in-place Arg1:T28 Arg2:T23	
R19	target Arg1:T28 Arg2:T21	
A1	Uncertain T28
T29	Action 496 504	detected
A2	Uncertain T29
T30	Action 496 504	detected
A3	Uncertain T30
T31	Action 496 504	detected
A4	Uncertain T31
T32	Action 496 504	detected
A5	Uncertain T32
R20	target Arg1:T32 Arg2:T21	
R21	target Arg1:T31 Arg2:T21	
R22	target Arg1:T30 Arg2:T21	
R23	target Arg1:T29 Arg2:T21	
R24	in-place Arg1:T32 Arg2:T24	
R25	in-place Arg1:T29 Arg2:T25	
R26	in-place Arg1:T30 Arg2:T26	
R27	in-place Arg1:T31 Arg2:T27	
T33	Action 464 473	expressed
A6	Emphasized T33
R28	subject Arg1:T33 Arg2:T21	
R29	in-place Arg1:T33 Arg2:T22	
T34	Concept 605 615	rod-shaped
T35	Concept 616 632	Ce:GAGG crystals
R30	has-property Arg1:T35 Arg2:T34	
T36	Action 633 642	implanted
T37	Concept 652 657	brain
T38	Concept 662 672	four weeks
R31	in-time Arg1:T36 Arg2:T38	
R32	in-place Arg1:T36 Arg2:T37	
R33	target Arg1:T36 Arg2:T35	
T39	Action 687 697	activation
A7	Negated T39
R34	causes Arg1:T36 Arg2:T39	
T40	Concept 701 712	glial cells
R35	subject Arg1:T39 Arg2:T40	
T41	Concept 749 761	optic fibers
T42	Concept 735 748	biocompatible
R36	has-property Arg1:T41 Arg2:T42	
T43	Action 687 697	activation
R37	subject Arg1:T43 Arg2:T40	
R38	causes Arg1:T41 Arg2:T43	
